Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125835961 | 12583596 | 1 | I | 20150420 | 20160718 | 20160722 | 20160722 | EXP | CN-JNJFOC-20160716941 | JANSSEN | 25.02 | YR | A | F | Y | 60.00000 | KG | 20160722 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125835961 | 12583596 | 1 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | Y | 141211322 | 0 | 2 | MG | TABLETS | QD | ||||
| 125835961 | 12583596 | 2 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | Y | 141211322 | 20272 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125835961 | 12583596 | 1 | Schizophrenia |
| 125835961 | 12583596 | 2 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125835961 | 12583596 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125835961 | 12583596 | Endocrine disorder | Endocrine disorder |
| 125835961 | 12583596 | Increased appetite | |
| 125835961 | 12583596 | Menstrual disorder | |
| 125835961 | 12583596 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125835961 | 12583596 | 1 | 20140323 | 20150420 | 0 |